Researcher awarded $2.75M NIH grant to develop next-gen cancer treatments
Grant and Award Announcement
Updates every hour. Last Updated: 8-Jun-2026 04:16 ET (8-Jun-2026 08:16 GMT/UTC)
A leading expert in antibody-drug-conjugate (ADC) technology, Binghamton University Professor of Pharmaceutical Sciences L. Nathan Tumey has worked for nearly two decades developing new approaches for the treatment of cancer. Now, thanks to a substantial $2.75M grant from the National Institutes of Health, Tumey is taking an exciting step forward in his research — leading the charge to transition this exciting technology platform for applications outside of oncology.
Scientists built a new theoretical model that learns from interactions. Positive interactions strengthened connections, and negative interactions weakened connections. Model revealed that strong connections can lead to feedback loops and echo chambers. Findings extend to diverse spreading systems, from social ideas to infections to animal behavior to neural signals.
Storing and transporting hydrogen safely and efficiently just got more promising. A new study in Engineering fine-tunes platinum’s d-electron structure via different oxide supports to boost the dehydrogenation of liquid organic hydrogen carriers. The Pt/MgO catalyst stands out with optimized activity and stability, offering a clear path to better hydrogen release catalysts for real‑world use.
According to a new federally funded study focusing on New York City and published in Environmental Epidemiology, researchers found that communities that were very isolated by roadways and traffic patterns tended to have more schizophrenia-related hospital visits, and this effect was independent from traffic-caused air pollution.